Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12649112rdf:typepubmed:Citationlld:pubmed
pubmed-article:12649112lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:12649112lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12649112lifeskim:mentionsumls-concept:C0205208lld:lifeskim
pubmed-article:12649112lifeskim:mentionsumls-concept:C0042672lld:lifeskim
pubmed-article:12649112lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:12649112lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:12649112lifeskim:mentionsumls-concept:C0672663lld:lifeskim
pubmed-article:12649112lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:12649112lifeskim:mentionsumls-concept:C0585333lld:lifeskim
pubmed-article:12649112lifeskim:mentionsumls-concept:C1521801lld:lifeskim
pubmed-article:12649112lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:12649112pubmed:issue4lld:pubmed
pubmed-article:12649112pubmed:dateCreated2003-3-21lld:pubmed
pubmed-article:12649112pubmed:abstractTextVinflunine is a novel vinca alkaloid obtained by semi-synthesis using super-acidic chemistry to selectively introduce two fluorine atoms at the 20' position of vinorelbine. In human tumour xenografts, vinflunine showed definite antitumour activity in seven out of 11 tumours tested compared with three out of 11 for vinorelbine.lld:pubmed
pubmed-article:12649112pubmed:languageenglld:pubmed
pubmed-article:12649112pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12649112pubmed:citationSubsetIMlld:pubmed
pubmed-article:12649112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12649112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12649112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12649112pubmed:statusMEDLINElld:pubmed
pubmed-article:12649112pubmed:monthAprlld:pubmed
pubmed-article:12649112pubmed:issn0923-7534lld:pubmed
pubmed-article:12649112pubmed:authorpubmed-author:MartyMMlld:pubmed
pubmed-article:12649112pubmed:authorpubmed-author:FumoleauPPlld:pubmed
pubmed-article:12649112pubmed:authorpubmed-author:PuozzoCClld:pubmed
pubmed-article:12649112pubmed:authorpubmed-author:RaymondEElld:pubmed
pubmed-article:12649112pubmed:authorpubmed-author:CamponiAAlld:pubmed
pubmed-article:12649112pubmed:authorpubmed-author:BennounaJJlld:pubmed
pubmed-article:12649112pubmed:authorpubmed-author:ArmandJ-PJPlld:pubmed
pubmed-article:12649112pubmed:authorpubmed-author:DelgadoF-MFMlld:pubmed
pubmed-article:12649112pubmed:issnTypePrintlld:pubmed
pubmed-article:12649112pubmed:volume14lld:pubmed
pubmed-article:12649112pubmed:ownerNLMlld:pubmed
pubmed-article:12649112pubmed:authorsCompleteYlld:pubmed
pubmed-article:12649112pubmed:pagination630-7lld:pubmed
pubmed-article:12649112pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:meshHeadingpubmed-meshheading:12649112...lld:pubmed
pubmed-article:12649112pubmed:year2003lld:pubmed
pubmed-article:12649112pubmed:articleTitlePhase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours.lld:pubmed
pubmed-article:12649112pubmed:affiliationCentre René Gauducheau, Nantes-Saint-Herblain, France. j-bennouna@nantes.fnclcc.frlld:pubmed
pubmed-article:12649112pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12649112pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12649112pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12649112lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12649112lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12649112lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12649112lld:pubmed